NCT06001385 2026-02-05OPTIMIZECenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting313 enrolled
NCT01589302 2025-07-25PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic LeukemiaOhio State University Comprehensive Cancer CenterPhase 2 Active not recruiting154 enrolled 18 charts